Financial Times: Will war on neglected diseases hit target?
“Five years ago [Sunday], the heads of some of the world’s largest pharmaceutical groups gathered in London with leading health experts, donors, and governments to commit to an unusual medicines program. In the London Declaration, they pledged to work together rather than compete in an innovative program, and to donate rather than charge for supplying large volumes of drugs. … The impact since has been significant. Yet some are nervous that progress may stall given a shift in global priorities and funding under new political and health leaders, and the challenges of tackling the diseases themselves…” (Jack, 1/29).